Related Experiment Video
Updated: May 10, 2026

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging
Published on: December 30, 2016
Estimating the Timeframe of Lactate Reduction in Acute Cardiovascular Disease Using Functional Data Analysis Based on
Takaya Nakashima1, Shuntaro Sato2, Hidetoshi Matsui3
1Department of Anesthesiology and Intensive Care Medicine, Nagasaki University Graduate School of Biomedical Sciences.
Abstract:
In patients with acute cardiovascular disease, treatment aimed at reducing lactate levels is crucial for improving prognosis. Trends in blood lactate levels for each specific cardiovascular disease can provide an accurate evaluation of the patient's condition. We used functional data analysis with nonlinear mixed effects models to estimate the timeframe of lactate reduction in 3 cardiovascular diseases (acute heart failure, aortic dissection, and ischemic heart disease) by analyzing lactate trends.Among 1,816 patients admitted to the intensive care unit (ICU) or intensive cardiovascular care unit (ICCU) of St. Luke's International Hospital for cardiology or cardiovascular surgery from December 31, 2010, to June 31, 2020, 1,249 adults with a diagnosis of acute heart failure (39%), aortic dissection (24%), or ischemic heart disease (37%) were included in the present study. Using functional data analysis with nonlinear mixed effects models, our study estimated the timeframe of lactate reduction based on blood lactate level trends. Lactate reduction took 30 hours (95% CI, 23-37 hours) in patients with acute heart failure, 40 hours (95% CI, 33-47 hours) in patients with aortic dissection, and 95 hours (95% CI, 49-failed estimate) in patients with ischemic heart disease.We were able to estimate the timeframe of lactate reduction with different cardiovascular diseases. Recognizing the differences in lactate reduction may be useful in developing treatment plans tailored to each disease.
More Related Videos
Related Concept Videos
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Pharmacodynamic Models: Linear Concentration–Effect Model
Pharmacodynamic Models: Logarithmic Concentration–Effect Model

